Exogenous stem cell therapy (SCT) has been recognized recently as a promising
neuroregenerative strategy to augment recovery in stroke survivors. Mesenchymal stem …

Mesenchymal stem cells (MSCs) can differentiate into not only cells of mesodermal
lineages, but also into endodermal and ectodermal derived elements, including neurons …

Mesenchymal stem cells (MSCs) have emerged as a potentially powerful cellular therapy for
autoimmune diseases including multiple sclerosis (MS). Based on their success in treating …

Background Multiple sclerosis (MS) typically arises in early/middle adulthood and is
characterized by a progressive disability of the central nervous system (CNS). Currently …

Diseases of the central nervous system still remain among the most challenging pathologies
known to mankind, having no or limited therapeutic possibilities and a very pessimistic …

Background: Stem-cell-based therapy is a promising new approach to handling
neurodegenerative diseases. One of the most promising cellular sources is bone-marrow …

Adult bone marrow-derived mesenchymal stem cells (MSCs) display a spectrum of
functional properties. Transplantation of these cells improves clinical outcome in models of …

Mesenchymal Stem Cells (MSCs) are one of the most promising tools for cell therapy, that
are isolated from bone marrow and many other adult tissues such as liver, cord blood …

Numerous preclinical studies have been carried out using mesenchymal stem cells (MSCs)
therapy for ischemic stroke. The purpose of the present meta‐analysis is to review the …

Background: Following extensive, positive results in pre-clinical experiments, Bone Marrow
Derived-Mesenchymal Stromal Cells (BM-MSCs) are now being tested as a novel therapy …